ArticleBlood research2014

Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy.

Pasquale Niscola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.